Compound Detail
CHEMBL40
PHENOBARBITAL 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL40 |
| Name | PHENOBARBITAL |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | DDBREPKUVSBGFI-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
1
Targets
4
Activities
1
Assay Types
30
PK Parameters
20
Publications
10
Known Names
10
Indications
Molecular Properties
232.2
MW (Da)
0.70
ALogP
3
HBA
2
HBD
75.3
PSA (Ų)
0.74
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2022 |
| Availability | Withdrawn |
| Chirality | Achiral |
Indications
Epilepsy Anxiety Dementia Depressive Disorder Neonatal Abstinence Syndrome Schizophrenia Status Epilepticus Lymphoma Neutropenia Seizures
ATC Classification
N03AA02
phenobarbital
Level 1: NERVOUS SYSTEM
Level 2: ANTIEPILEPTICS
Drug Warnings
Withdrawn
drug misuse
Fatal intoxications and abuse
Activity Summary
IC50 4 meas. best 5.6
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Sodium channel alpha subunits; brain (Types I, II, III) CHEMBL2095171 | IC50 | 5.6 | 5.6 | 2500.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 0.063 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.0479 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.063 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.063 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.05 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.01333 | mL.min-1.kg-1 | Homo sapiens |
| Cmax | 23682.4 | nM | Homo sapiens |
| F | 80.0 | % | Homo sapiens |
| F | 96.0 | % | Homo sapiens |
| F | 100.0 | % | Homo sapiens |
| F | 94.9 | % | Homo sapiens |
| F | 83.4 | % | Homo sapiens |
| Fu | 0.49 | - | Homo sapiens |
| Fu | 0.49 | - | Homo sapiens |
| MRT | 140.0 | hr | Homo sapiens |
| T1/2 | 99.0 | hr | Homo sapiens |
| T1/2 | 117.0 | hr | Homo sapiens |
| T1/2 | 84.0 | hr | Homo sapiens |
| T1/2 | 61.0 | hr | Homo sapiens |
| T1/2 | 83.0 | hr | Homo sapiens |
| T1/2 | 119.0 | hr | Homo sapiens |
| T1/2 | 149.0 | hr | Homo sapiens |
| T1/2 | 128.0 | hr | Homo sapiens |
| T1/2 | 147.0 | hr | Homo sapiens |
| T1/2 | 122.0 | hr | Homo sapiens |
| T1/2 | 139.0 | hr | Homo sapiens |
| T1/2 | 0.18 | hr | Homo sapiens |
| Tmax | 50.0 | hr | Homo sapiens |
| Tmax | 18.0 | hr | Homo sapiens |
| Tmax | 2.3 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Sodium channel alpha subunits; brain (Types I, II, III) | IC50 | = | 2500.0 | nM | 5.6 | Inhibition of [3H]BTX-B binding to neurotoxin site 2 of sodium channel of rat ce... | 7562939 |
Literature References
Data from ChEMBL 36 via Core Engine